Marshall Wace’s Zepp Health ZEPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$136K Buy
+26,153
New +$274K ﹤0.01% 2888
2025
Q4
Sell
-62,569
Closed -$2.86M 3576
2025
Q3
$2.86M Buy
+62,569
New +$1.9M ﹤0.01% 1440
2023
Q1
Sell
-11,682
Closed -$67.8K 3167
2022
Q4
$67.8K Sell
11,682
-29,111
-71% -$156K ﹤0.01% 2826
2022
Q3
$222K Sell
40,793
-14,693
-26% -$106K ﹤0.01% 3056
2022
Q2
$410K Buy
55,486
+8,508
+18% +$78.3K ﹤0.01% 2888
2022
Q1
$543K Buy
+46,978
New +$759K ﹤0.01% 2738
2021
Q2
Sell
-11,227
Closed -$484K 3170
2021
Q1
$484K Buy
+11,227
New +$652K ﹤0.01% 1954
2020
Q1
Sell
-757
Closed -$36K 2125
2019
Q4
$36K Sell
757
-935
-55% -$39.2K ﹤0.01% 1570
2019
Q3
$67K Sell
1,692
-64,408
-97% -$2.7M ﹤0.01% 1441
2019
Q2
$2.64M Buy
66,100
+60,206
+1,021% +$2.51M 0.02% 691
2019
Q1
$309K Buy
5,894
+5,741
+3,752% +$310K ﹤0.01% 1256
2018
Q4
$6K Buy
+153
New +$6.01K ﹤0.01% 1542

Other funds holding ZEPP

Marshall Wace's ZEPP Position: Q2 2026 in Review

Marshall Wace opened a new position in Zepp Health (ZEPP) in Q2 2026: 26,153 shares worth $136K. The stake represents ﹤0.01% of the portfolio and ranks #2888 among its holdings. This is a return to the name: Marshall Wace previously reported a position in ZEPP as recently as Q3 2025.

Marshall Wace first reported a position in ZEPP in Q4 2018 and has held it in 12 quarters since. The position peaked at $2.86M in Q3 2025. 28 funds tracked by Wall St. Rank hold ZEPP as of Q2 2026.

  • Marshall Wace held 26,153 shares of Zepp Health worth $136K as of Q2 2026.
  • Zepp Health was a new Marshall Wace position in Q2 2026.
  • Zepp Health made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2888 holding.
  • Marshall Wace first reported a position in Zepp Health in Q4 2018 and has held it in 12 quarters since.
  • Marshall Wace's Zepp Health position peaked at $2.86M in Q3 2025.
  • 28 funds tracked by Wall St. Rank held Zepp Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.